Zora Nováková

1.4k total citations
46 papers, 991 citations indexed

About

Zora Nováková is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Zora Nováková has authored 46 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Zora Nováková's work include Peptidase Inhibition and Analysis (11 papers), Histone Deacetylase Inhibitors Research (11 papers) and Protein Degradation and Inhibitors (6 papers). Zora Nováková is often cited by papers focused on Peptidase Inhibition and Analysis (11 papers), Histone Deacetylase Inhibitors Research (11 papers) and Protein Degradation and Inhibitors (6 papers). Zora Nováková collaborates with scholars based in Czechia, United States and Germany. Zora Nováková's co-authors include Cyril Bařinka, Zsófia Kutil, Jana Mikešová, Mike Schutkowski, Marat Meleshin, Zdeněk Hodný, Pavel Hozák, Lenka Rossmeislová, Ka Yang and Jana Dobrovolná and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Zora Nováková

43 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zora Nováková Czechia 20 681 341 159 137 92 46 991
Yi-Wen Chu Taiwan 8 806 1.2× 305 0.9× 122 0.8× 128 0.9× 103 1.1× 8 1.3k
Ismail Hassan Ismail Canada 17 1.2k 1.8× 441 1.3× 95 0.6× 143 1.0× 69 0.8× 27 1.5k
Flonné Wildes United States 21 849 1.2× 426 1.2× 128 0.8× 140 1.0× 111 1.2× 43 1.4k
Mark Esposito United States 13 786 1.2× 466 1.4× 61 0.4× 172 1.3× 138 1.5× 19 1.3k
Denis M. Collins Ireland 20 479 0.7× 671 2.0× 282 1.8× 210 1.5× 139 1.5× 53 1.2k
Suresh Veeramani United States 15 521 0.8× 254 0.7× 211 1.3× 314 2.3× 272 3.0× 23 1.0k
Linda Kessler United States 14 746 1.1× 352 1.0× 73 0.5× 106 0.8× 127 1.4× 38 1.1k
Andrea Viale Italy 13 957 1.4× 361 1.1× 58 0.4× 61 0.4× 136 1.5× 19 1.3k

Countries citing papers authored by Zora Nováková

Since Specialization
Citations

This map shows the geographic impact of Zora Nováková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zora Nováková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zora Nováková more than expected).

Fields of papers citing papers by Zora Nováková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zora Nováková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zora Nováková. The network helps show where Zora Nováková may publish in the future.

Co-authorship network of co-authors of Zora Nováková

This figure shows the co-authorship network connecting the top 25 collaborators of Zora Nováková. A scholar is included among the top collaborators of Zora Nováková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zora Nováková. Zora Nováková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Motlova, L., Zora Nováková, Irina Gutsche, et al.. (2025). Mechanistic insights into TTLL11 polyglutamylase–mediated primary tubulin chain elongation. Science Advances. 11(34). eadw1561–eadw1561.
3.
Liatsou, Ioanna, et al.. (2025). Optical and MRI-Guided Theranostic Application of Ultrasmall Superparamagnetic Iron Oxide Nanodrug Conjugate for PSMA-Positive Prostate Cancer Therapy. ACS Applied Materials & Interfaces. 17(8). 11611–11623. 5 indexed citations
4.
McNicoll, François, Prasoon Kumar Thakur, Michaela Blažíková, et al.. (2025). Retinitis pigmentosa-linked mutations impair the snRNA unwinding activity of SNRNP200 and reduce pre-mRNA binding of PRPF8. Cellular and Molecular Life Sciences. 82(1). 103–103. 1 indexed citations
5.
Liatsou, Ioanna, Wathsala Liyanage, Zora Nováková, et al.. (2024). Development and therapeutic evaluation of 5D3(CC-MLN8237)3.2 antibody-theranostic conjugates for PSMA-positive prostate cancer therapy. Frontiers in Pharmacology. 15. 1385598–1385598. 2 indexed citations
6.
Benický, Július, et al.. (2024). Galectin-3-Binding Protein Inhibits Extracellular Heparan 6-O-Endosulfatase Sulf-2. Molecular & Cellular Proteomics. 23(7). 100793–100793. 1 indexed citations
7.
Kolenko, Petr, et al.. (2023). Conformation-based refinement of 18-mer DNA structures. Acta Crystallographica Section D Structural Biology. 79(7). 655–665. 1 indexed citations
8.
Nováková, Zora, et al.. (2022). In‐solution structure and oligomerization of human histone deacetylase 6 – an integrative approach. FEBS Journal. 290(3). 821–836. 2 indexed citations
9.
Mikešová, Jana, et al.. (2022). Determining Potency of Inhibitors Targeting Histone Deacetylase 6 by Quantification of Acetylated Tubulin in Cells. Methods in molecular biology. 2589. 455–466. 1 indexed citations
10.
Nováková, Zora, et al.. (2021). Heterologous expression and purification of recombinant human protoporphyrinogen oxidase IX: A comparative study. PLoS ONE. 16(11). e0259837–e0259837. 2 indexed citations
11.
Cardinale, Jens, Mareike Roscher, Martin Schäfer, et al.. (2020). Development of PSMA-1007-Related Series of 18F-Labeled Glu-Ureido-Type PSMA Inhibitors. Journal of Medicinal Chemistry. 63(19). 10897–10907. 24 indexed citations
12.
Nováková, Zora, Makoto Saito, Marat Meleshin, et al.. (2020). The disordered N-terminus of HDAC6 is a microtubule-binding domain critical for efficient tubulin deacetylation. Journal of Biological Chemistry. 295(9). 2614–2628. 31 indexed citations
13.
Kutil, Zsófia, Marat Meleshin, Zora Nováková, et al.. (2019). One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity. Biochemistry. 58(48). 4777–4789. 27 indexed citations
14.
Conway, Rebecca, Camilo Rojas, Jesse Alt, et al.. (2016). Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide. Angiogenesis. 19(4). 487–500. 56 indexed citations
15.
Nováková, Zora, Cindy J. Choy, Jessie R. Nedrow, et al.. (2015). Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities. FEBS Journal. 283(1). 130–143. 24 indexed citations
16.
Vacková, Irena, et al.. (2014). Absence of maternal cell contamination in mesenchymal stromal cell cultures derived from equine umbilical cord tissue. Placenta. 35(8). 655–657. 4 indexed citations
17.
Hubáčková, Soňa, Zora Nováková, Kateřina Krejčíková, et al.. (2010). Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling. Cell Cycle. 9(15). 3157–3171. 44 indexed citations
18.
Fulka, J., et al.. (2009). How to Repair the Oocyte and Zygote?. Journal of Reproduction and Development. 55(6). 583–587. 7 indexed citations
19.
Rossmeislová, Lenka, et al.. (2007). PML protein association with specific nucleolar structures differs in normal, tumor and senescent human cells. Journal of Structural Biology. 159(1). 56–70. 27 indexed citations
20.
Nováková, Zora, Petr Man, Petr Novák, Pavel Hozák, & Zdeněk Hodný. (2006). Separation of nuclear protein complexes by blue native polyacrylamide gel electrophoresis. Electrophoresis. 27(7). 1277–1287. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi-Wen Chu Breakdown of academic impact, for papers by Ismail Hassan Ismail Breakdown of academic impact, for papers by Flonné Wildes Breakdown of academic impact, for papers by Mark Esposito Breakdown of academic impact, for papers by Denis M. Collins Breakdown of academic impact, for papers by Suresh Veeramani Breakdown of academic impact, for papers by Linda Kessler Breakdown of academic impact, for papers by Andrea Viale
Rankless by CCL
2026